Cargando…
A phase I study of regional 5-fluorouracil and systemic folinic acid for patients with colorectal liver metastases.
A phase I study was undertaken in order to establish the maximum tolerated dose of intra-hepatic arterial 5-fluorouracil (5-FU) when given in combination with systemic folinic acid. Patients with colorectal liver metastases (n = 10) received escalating doses of 5-FU as a 24 h infusion with a fixed d...
Autores principales: | Anderson, J. H., Kerr, D. J., Cooke, T. G., McArdle, C. S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977775/ https://www.ncbi.nlm.nih.gov/pubmed/1616863 |
Ejemplares similares
-
A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastases.
por: Warren, H. W., et al.
Publicado: (1994) -
A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases.
por: Howell, J. D., et al.
Publicado: (1997) -
A pharmacokinetic comparison of intravenous versus intra-arterial folinic acid.
por: Anderson, J. H., et al.
Publicado: (1992) -
Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases.
por: Goldberg, J. A., et al.
Publicado: (1988) -
5-Fluorouracil and folinic acid: interesting biochemistry or effective treatment?
por: Kerr, D. J.
Publicado: (1989)